News

PTO Litigation Center Report – October 27, 2015

October 27th, 2015

Listed below are all new filings before PTAB of requests for inter partes review (IPR) and covered business methods review (CBM).  Since the last report, no new requests for ex parte reexamination at the USPTO have been posted.  This listing is current as of 10 AM on Tuesday, October 27, 2015.

New IPR Requests

Trial Number – IPR2016-00062
Filing Date – 10/26/2015
Patent # – 6,502,135
Title – AGILE NETWORK PROTOCOL FOR SECURE COMMUNICATIONS WITH ASSURED SYSTEM AVAILABILTY
Patent Owner –  VIRNETX INC.
Petitioner – APPLE INC.
Tech Center – 2100

Trial Number – IPR2016-00063
Filing Date – 10/26/2015
Patent # – 7,490,151
Title – ESTABLISHMENT OF A SECURE COMMUNICATION LINK BASED ON A DOMAIN NAME SERVICE (DNS) REQUEST
Patent Owner –  VIRNETX INC.
Petitioner – APPLE INC.
Tech Center – 2100

Trial Number – IPR2016-00074
Filing Date – 10/26/2015
Patent # – 7,741,338
Title – MACROLIDES
Patent Owner –  NOVARTIS AG
Petitioner – Par Pharmaceutical, Inc.
Tech Center – 1600

Trial Number – IPR2016-00075
Filing Date – 10/26/2015
Patent # – 7,297,703
Title – MACROLIDES
Patent Owner –  NOVARTIS AG
Petitioner – Par Pharmaceutical, Inc.
Tech Center – 1600

Trial Number – IPR2016-00078
Filing Date – 10/26/2015
Patent # – 6,455,518
Title – PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TRANSPLANT REJECTION, AUTOIMMUNE OR INFLAMMATORY CONDITIONS COMPRISING CYCLOSPORIN A AND 40-O-(2-HYDROXYETHYL)-RAPAMYCIN
Patent Owner –  NOVARTIS AG
Petitioner – Par Pharmaceutical, Inc.
Tech Center – 1600

Trial Number – IPR2016-00084
Filing Date – 10/26/2015
Patent # – 5,665,772
Title – O-ALKYLATED RAPAMYCIN DERIVATIVES AND THEIR USE, PARTICULARLY AS IMMUNOSUPPRESSANTS
Patent Owner –  NOVARTIS AG
Petitioner – Par Pharmaceutical, Inc.
Tech Center – 1200

Trial Number – IPR2016-00085
Filing Date – 10/26/2015
Patent # – 7,829,595
Title – RAPID DISSOLUTION FORMULATION OF A CALCIUM RECEPTOR-ACTIVE COMPOUND
Patent Owner –  AMGEN INC.
Petitioner – COMPLEX INNOVATIONS, LLC
Tech Center – 1600

New CBM Review Requests

There have been no new requests for CBM review since the last report.

Newly-Posted Reexam Requests

There have been no new reexam requests posted since the last report.